Evotec : CVs of the Supervisory Board candidates on agenda item 8,

Curriculum Vitae

Prof. Dr Iris Löw-Friedrich

Name:	Prof. Dr med. Iris Löw-
Friedrich
Year of birth:	1960
Nationality:	German
First appointment:	2019

Current appointment until: 2024

Current occupation:

• Chief Medical Officer UCB S.A., Brussels/Belgium (retiring from UCB in the course of 2024)
• Clinical professor for internal medicine, University of Frankfurt am Main Medical School, Frankfurt am Main/Germany (visiting, since 2000)

Professional career:

2008 - 2024	UCB S.A.
	Chief Medical Officer and Vice President Development
2001 - 2009	Pharma AG
	Global Head of Research and Development; since 2008 with UCB,
	following the acquisition of Schwarz Pharma AG
2000 - 2001	BASF Pharma
	Vice President Global Projects
Since 2000	University of Frankfurt/Main
	Clinical professor for internal medicine
	(visiting)
1992 - 2000	Hoechst AG
	Various positions in Clinical Development, most recent position of Vice
	President Clinical Development

25

Qualifications:
1992	University of Frankfurt/Main, Faculty of Medicine:
	Venia legendi (Habilitation)
1985	University of
	Frankfurt/Main Conferral
	of a doctorate (Dr. med.)
1979 - 1985	University of
	Frankfurt/Main
	Study of medicine

Special qualifications as part of the skills profile or skills matrix:

• Research & Development
• Biopharma
• Healthcare economics
• Capital Markets
• Digitalization
• General Management
• Social and HR
• Governance

Current group mandates:
• Fresenius SE & Co. KGaA, Bad Homburg/DE	Member of the Supervisory
	Board
	(Listed on the Frankfurt, Düsseldorf
	and München Stock Exchange)
Other current mandates:
•	PhRMA Foundation, Washington/USA	Member of the Board of Directors
	(not listed)
•	TransCelerate BioPharma Inc.,	Member of the Supervisory Board
	West Conshohocken, PA/USA
	(not listed)

Latest update: April 2024

26

Curriculum Vitae

Roland Sackers

Name:	Roland Sackers
Year of birth:	1968
Nationality:	German
First appointment:	2019

Current appointment until: 2024

Current occupation:

• Chief Financial Officer and Managing Director, QIAGEN N.V., Venlo/NL

Professional career:

Since Jan. 2004	QIAGEN N.V.
	Chief Financial Officer
1999 - 2004	QIAGEN N.V.
	Vice President Finance
1995 - 1999	Arthur Andersen Wirtschaftsprüfungsgesellschaft mbH
	Auditor
Qualifications:
1995	Master Degree in Business Administration (Diplom-
	Kaufmann), University of Münster/DE

27

Special qualifications as part of the skills profile or skills matrix:

• Capital Markets
• Accounting / P&L / Risk Management
• Auditing & Sustainability Reporting
• Controlling
• Digitization
• IT and Cybersecurity
• General Management
• Legal & Compliance
• Environment, Sustainability & Governance
• Procurement
• Investor & Corporate Communications
• Shared Services, Process & Commercial Excellence
• Social and HR
• Governance

Current group mandates:
• BIO Deutschland e.V., Berlin/DE	Member of the Board
(not listed)

Other current mandates:

• n/a

Latest update: April 2024

28

Curriculum vitae

Camilla Macapili Languille

Name:		Camilla Macapili Languille
Year of birth:		1983
Nationality:		Canadian
First appointment:		2022

Current appointment until: 2024

Current occupation:

• Head of Life Sciences, Mubadala Investment Company (MIC), Abu Dhabi, UAE

Professional career:
Since 2013	Mubadala Investment Company (MIC), Abu Dhabi, UAE:
Since 2018	Director, Head of Life Sciences and DI Investment Committee
	member
2016 - 2018	Senior Vice President, Technology
2013 - 2015	Utilities & Mining - Vice President, Head of Power
2011 - 2013	DAIWA CAPITAL (DC) ADVISORY PARTNERS, Paris, France
	Mergers & Acquisitions - Senior Manager
2007 - 2010	VIRGIN MANAGEMENT LTD. (VIRGIN GROUP), London, UK
	Corporate Finance & Special Situations Portfolio - Investment
	Manager
2005 - 2007	JPMORGAN SECURITIES, INC., London, UK & New York, USA
	Mergers & Acquisitions, Consumer Healthcare & Retail - Analyst
Qualifications
2011	Cours de Civilisation Française, Université Paris Sorbonne-IV
2004	Bachelor of Arts, Economics and Political Science, Columbia University,
	New York, USA

29

Special qualifications as part of the skills profile or skills matrix:

• Biologics Manufacturing
• Biopharma
• Small Biotech
• Healthcare economics
• Capital Markets
• Accounting / P&L / Risk Management
• General Management
• Environment and Sustainability
• Governance

Current group mandates:
• PCI Pharma Services (KPCI Holdings Limited),	Member of the Board of Directors
	Philadelphia/USA
	(not listed)
• Norstella (Caerus PikCo S.A.R.L.), New York/USA	Member of the Board of Directors
	(not listed)
•	Envirotainer A/S, Stockholm/SE	Member of the Board of Directors
	(not listed)
•	va-Q-tec AG, Würzburg/DE	Member of the Board of Directors
	(listed on the Frankfurt Stock Exchange
	until 30 August 2023)

Other current mandates:

• n/a

Latest update: April 2024

30

Curriculum Vitae

Dr Constanze Ulmer-Eilfort

Name:	Dr Constanze Ulmer-Eilfort
Year of birth:	1962
Nationality:	German
First appointment:	2021

Current appointment until: 2024

Current occupation:

• Partner of the law firm Peters, Schönberger & Partner, Munich/Germany

Professional career:
Since 2022	Partner at the law firm Peters, Schönberger & Partner (PSP Munich)
Until 2021	Equity Partner at Baker McKenzie
2012 - 2017	Managing Partner in the German and Austrian offices of
	Baker McKenzie
2017 - 2021	Member of the Global Executive Committee of Baker McKenzie
Since 1994	Baker McKenzie
Qualifications:
1993	2nd State Legal Examination, Ludwig-Maximilians-Universität, Munich
1993	Doctorate (Dr. iur.)
1989	LL.M., University of Pennsylvania Carey Law School
1987	1st State Legal Examination, Ludwig-Maximilians-Universität, Munich

31

Special qualifications as part of the skills profile or skills matrix:

• M&A / Partnering
• General Management
• Legal & Compliance
• Environment and Sustainability, Sustainability Reporting
• Social and HR
• Governance

Current group mandates:
•	Affimed NV, Mannheim/DE	Member of the Supervisory Board
	(listed on the NASDAQ)
•	Proxygen GmbH, Vienna/AT	Member of the Advisory Board
	(not listed)

Other current mandates:

• n/a

Latest update: April 2024

32

Curriculum Vitae

Dr Duncan McHale

Name:	Dr Duncan Philip McHale
Year of birth:	1966
Nationality:	British
First appointment:	2024

Current appointment until: -

Current occupation:

• Founder and Company Director of Weatherden Ltd, London, UK

Professional career:
Since 2017	Weatherden Ltd
	Founder and Company Director
2017 - 2023	Evelo
Biosciences	Chief Medical Officer
2011 - 2017	UCB
	Vice President and Head Global Exploratory Development
208 - 2011	AstraZeneca
	Various positions, most recent position of Vice President
	Personalized Healthcare and Biomarkers
1999 - 2007	Pfizer
	Various positions, most recent position of Executive Director,
	European Head of Molecular Profiling and TA lead for Pain, Sex Health

and Urology, Sandwich Laboratories, Pfizer Global Research and Development

33

Qualifications:
1996 - 1999	Doctor of Philosophy - PhD, Human/Medical Genetics,
	University of Leeds, Leeds, UK
1985 - 1991	Bachelor of Medicine, Bachelor of Surgery, University of
	Newcastle-Upon-Tyne,Newcastle-Upon-Tyne, UK

Special qualifications as part of the skills profile or skills matrix:

• Research & development
• General Management
• M&A / Partnering
• Environment & Sustainability
• Governance

Current group mandates:

• n/a

Other current mandates:

• n/a

Latest update: April 2024

34